Africa

Thirty-three people are confirmed dead after a building collapsed onto another in the city of Douala.

Mohamed was born by the roadside as his mother Arafa crossed into Chad, fleeing the fighting in Sudan.

Germany begin their Women's World Cup campaign in style as captain Alexandra Popp scores twice to see off debutants Morocco in Melbourne.

Trailblazing forward Ghizlane Chebbak on the enduring influence of her late father, Larbi - a star of Morocco's only Africa Cup of Nations win.

Trailblazing forward Ghizlane Chebbak on the enduring influence of her late father, Larbi - a star of Morocco's only Africa Cup of Nations win.

Deer sanctuary at Nijhum Dwip – the island of tranquility.

By Ramiz Uddin and Mohammad Saiful Hassan
DHAKA, Bangladesh, Jul 24 2023 (IPS)

Blue tourism, widely referred to as Coastal or Maritime tourism, is a distinct idea from traditional tourism, which capitalizes on a country’s ocean, sea, or coastal region.

Coastal tourism is the largest market segment in the world, accounting for 5% of GDP and contributing 6-7% of total employment. Furthermore, coastal and maritime tourism will employ 1.5 million additional people worldwide by 2030.

Though Blue Tourism is not a new concept, but off late Bangladesh has been realizing its importance as it can help earning a lot of foreign exchange contribute to its GDP and accelerate the pace of achieving SDGs by 2030.

Blue Tourism: A Potential Blue Economy Avenue for Bangladesh

According to Asian Development Bank (ADB), coastal and maritime tourism has immense potential in the blue economy and could become one of the largest sources of tourism revenue in Bangladesh. Ocean contributed $6.2 billion in 2015 in total value addition to the Bangladesh’s economy which implies 3 percent of GDP (Business Standard 2020).

Among different sectors of the Blue Economy, Blue Tourism is the most potential sector.

Figure: Why blue tourism shall be nurtured

Potentials of Blue Tourism in Bangladesh

Maritime area of 207K sq. km, with 580 km of coastline, 200 nautical mile exclusive economic zone, and 12 nautical mile territorial zones creates unprecedent opportunities for Bangladesh to accelerate the growth of blue economy.

Icing on the top are the 75 large and small islands in the coastal and maritime zone of Bangladesh, which are regarded as touristy sites for their rich biodiversity. Coral reefs, seagrass reefs, sandy beaches, sandbars, marshes, flood basins, estuaries, peninsulas, mangroves etc. are a few examples of the aquatic life.

Currently these zones are endowed with 17 fish sanctuaries, 5 national parks, and 10 wildlife sanctuaries, all of which can spur the tourism sector’s expansion. As a result of the discovery of numerous new sea beaches, the sector continues to expand and diversify.

Policies and interventions introduced to nurture the potential

The government of Bangladesh along with the vibrant private sector have introduced various initiatives to develop and promote blue tourism in Bangladesh.

Since 2015, the Government of Bangladesh (GoB) has been working to unleash the potentials of Blue-Economy. To ensure rapid implementation Government of Bangladesh (GoB) has highlighted major action points in the seventh five-year plan (7FYP) and eighth five -year plan (8FYP) of Bangladesh.

Additionally, the Ministry of Foreign Affairs (MoFA), GoB, had formed the “Blue Economy Cell” in 2017 to coordinate the running blue economy related projects across sectoral ministries and departments. The government of Bangladesh has also laid emphasis on the BLUE tourism in different development plans including Perspective Plan-2041, and Delta Plan-2100.

In order to exploit the tourism potential, Sea cruises between Bangladesh and India have already been launched in March 2019. To encourage foreign visitors to Cox’s Bazar’s largest sea beach, the Bangladesh Economic Zone Authority (BEZA) has been establishing three exclusive tourism parks there. These parks include Naf Tourism Park, Sabrang Tourism Park, and Sonadia Eco-Tourism Park.

Bangladesh Tourism Board has formulated a Tourism Master Plan for 25 years (2023-2047) for the country. Primarily a total of 255 tourist sites under 11 tourist clusters have been identified.

These tourist sites are potential for Eco-Tourism, Beach & Island Tourism, Pilgrimage/Spiritual Tourism, Archaeological & Historical Tourism, Riverine Tourism, Adventure and Sports Tourism, Rural Tourism, Ethno-tourism, MICE Tourism and Cruise Tourism in this coastal and maritime region.

The tourism master plan includes 200+ potential interventions overall. The Bangladesh Tourism Master Plan calls for the immediate development of 13 islands altogether in the coastal region.

Bangladesh Tourism Board (BTB) and UNDP Accelerator Lab Bangladesh’s Joint Initiative:

In the last quarter of 2022, Bangladesh Tourism Board (BTB) in collaboration with UNDP Accelerator Lab has conducted research on Blue Tourism in Bangladesh, especially in the coastal regions. The core objectives of the joint research comprise identifying the coastal and maritime tourism resources, facilities, and tourist activities in Bangladesh, mapping tourist minds, and identifying the sustainability of Blue Tourism in Bangladesh.

However, with the technical assistance of UNDP Bangladesh Accelerator Lab, Bangladesh Tourism Board (BTB) has begun to work on the execution of Bangladesh’s Tourism Master Plan.

Dr. Ramiz Uddin is Head of Experimentation, UNDP Accelerator Lab, Bangladesh; Mohammad Saiful Hassan is (Deputy Secretary), Deputy Director (Research and Planning), Bangladesh Tourism Board, Ministry of Civil Aviation and Tourism – Bangladesh.

Source: UNDP

IPS UN Bureau

 

Follow @IPSNewsUNBureau
!function(d,s,id){var js,fjs=d.getElementsByTagName(s)[0],p=/^http:/.test(d.location)?'http':'https';if(!d.getElementById(id)){js=d.createElement(s);js.id=id;js.src=p+'://platform.twitter.com/widgets.js';fjs.parentNode.insertBefore(js,fjs);}}(document, 'script', 'twitter-wjs');  

Transgender people often entertain at weddings and other events, but they increasingly face violent acts, especially since part of an Act ensuring their rights was recently struck down. Credit: Ashfaq Yusufzai/IPS

By Ashfaq Yusufzai
PESHAWAR, Jul 24 2023 (IPS)

“The problems transgender people face start from their homes as their parents, especially fathers and brothers, look them down upon and disrespect them,” says 20-year-old Pari Gul.

Gul, a resident of Charsadda district in Khyber Pakhtunkhwa (KP), left her house at 16 when her mother asked her to or face being killed by her father.

“I was born as a boy, and my name was Abdul Wahid, but when I came to Peshawar and joined a transgender group, I got a female name, Pari Gul. Since then, I have been going to weddings and other festive ceremonies to dance,” she says. “Dance is my passion.”

However, she has often been the brunt of discrimination and violence.

“During my five-year career, people have beaten me more than 20 times. Each time the perpetrators went unpunished,” she told IPS in an interview.

Trans people are often targeted in KP, one of Pakistan’s four provinces.

On March 28, a man shot dead a transgender person in Peshawar. It was the third incident targeting transgender persons in the province in less than a week. Despite the violence, violent attacks on transgender people aren’t considered a major crime.

Khushi Khan, a senior transgender person, says lack of protection is the main problem.

“People have developed a disdain for us. They consider us non-Muslims because we dance at marriages and other ceremonies,” she says.

“We had lodged at least a dozen complaints with police in the past three months when our colleagues were robbed of money, molested and raped but to no avail,” Khan, 30, says.

Last month, clerics in the Khyber district decided they wouldn’t offer funerals to transgender persons and asked people to boycott them.

Rafiq Shah, a social worker, says that people attack the houses of transgender, kill, injure and rob them, but the police remain silent “spectators”.

“We have been protesting against violence frequently, but the situation remains unchanged,” Shah said.

Qamar Naseem, head of Blue Veins, a national NGO working to promote and protect transgender people, isn’t happy over the treatment meted out to the group.

“Security is the main issue of transgender persons. About 84 transgender persons have been killed in Pakistan since 2015 while another 2,000 have faced violence, but no one has been punished so far,” Naseem says.

The lack of action by the police has emboldened the people.

“Health, transportation, livelihoods and employment issues have hit the transgender (community) hard. Most of the time, they remained confined to their homes, located inside the city,” he says.

There are no data regarding the number of transgender in the country because the government doesn’t take them seriously, he says.

In May 2023, the Federal Shariat Court (FSC) dealt a severe blow when it suspended the implementation rules of the Protection of Transgender Persons Protection of Rights Act.

Farzana Jan, president of TransAction Alliance, says that FSC’s declaration that individuals cannot alter their gender at their own discretion, asserting that specific clauses within the Transgender Persons (Protection of Rights) Act, 2018 contradict Islamic law, has disappointed us.

The FSC declared un-Islamic sections 3 and 7 and two sub-sections of Section 2 of the Transgender Persons (Protection of Rights) Act, 2018, five years after the law was passed, the FSC rolled back key provisions granting rights to Pakistan’s transgender community.

Some right-wing political parties had previously voiced concerns over the bill as a promoter of “homosexuality,” leading to “new social problems”.

The Transgender Persons (Protection of Rights) Act, 2018, is against the injunctions of Islam as laid down in the Holy Quran and Sunnah of the Holy Prophet (PBUH) and will cease to have any legal effect immediately, the verdict stated.

Amnesty International said the verdict was a blow to the rights of the already beleaguered group of transgender and gender-diverse people in Pakistan. It said some of the FSC’s observations were based on presumptive scenarios rather than empirical evidence. The denial of essential rights of transgender and gender-diverse persons should not be guided by assumptions rooted in prejudice, fear and discrimination, AI said.

“Any steps taken by the government of Pakistan to deny transgender and gender-diverse people the right to gender identity is in contravention of their obligations under international human rights law, namely the International Covenant on Civil and Political Rights (ICCPR) and the Convention on the Elimination of All Forms of Discrimination against Women (CEDAW) to which they are a state party,” it said.

The government should take immediate steps to stop the reversal of essential protections, without which transgender and gender-diverse people will be even more at risk of harassment, discrimination and violence, AI added.

On July 12, 2023, transgender representatives from all provinces held a press conference at Lahore Press Club, where they vehemently condemned the recent decision by the FSC against the Transgender Persons (Protection of Rights) Act, 2018.

Arzoo Bibi, who was at a press conference, said it was time to stand united for justice and equality.

“Militants don’t threaten us, but our biggest concern is the attitude of the society and police,” said Arzoo.
IPS UN Bureau Report

 

Follow @IPSNewsUNBureau
!function(d,s,id){var js,fjs=d.getElementsByTagName(s)[0],p=/^http:/.test(d.location)?'http':'https';if(!d.getElementById(id)){js=d.createElement(s);js.id=id;js.src=p+'://platform.twitter.com/widgets.js';fjs.parentNode.insertBefore(js,fjs);}}(document, 'script', 'twitter-wjs');   Related Articles

• Food Insecurity Fears as Pakistan Faces Cyclone, Monsoon Season
• Theatre Used to Dispel Polio Immunisation Myths in Pakistan
• Afghan Tailors Flee to Pakistan After Ban on Stitching Women’s Clothing

In a Mexican city with buildings that reflect its level of modernization, a truck collects waste, mainly plastic, ignoring higher standards of care for health and the environment. Plastic garbage is just the tip of a serious social and environmental problem in Latin America and the Caribbean. CREDIT: Greenpeace

By Humberto Márquez
CARACAS, Jul 24 2023 (IPS)

Countries in Latin America and the Caribbean have made progress towards partial regulations to reduce plastic pollution, but the problem is serious and environmental activists are calling for regulations in the entire chain of production, consumption and disposal of plastic waste.

The release of plastic waste into the environment “is the tip of the iceberg of a problem that begins much earlier, from the exploitation of hydrocarbons, to the transport and transformation of these precursors of an endless number of products,” Andrés del Castillo, a Colombian expert based in Switzerland, told IPS."That is why our main call is for an immediate moratorium on increased plastics production, followed by a phased out reduction in supply, and complemented by other crucial measures such as reuse and landfill systems." -- Andrés del Castillo

Ecuadorian biologist María Esther Briz, an activist with the international campaign Break Free From Plastic, said “plastic pollution in our countries is not on its way to becoming a big problem: it already is.”

“From the extraction of raw materials, since we know that 99 percent of plastic is made from fossil fuels – oil and gas – plus the pollutants that are released during the transformation into resins and in consumption, and in the more well-known phase of when they become waste, our region is already very much affected,” the activist told IPS from the Colombian city of Guayaquil.

Plastic production in the region exceeds 20 million tons per year – almost five percent of the global total of 430 million tons per year – and consumption stands at 26 million tons per year, according to the Global Alliance for Incinerator Alternatives (GAIA), a coalition of 800 environmental organizations.

In the region, the largest installed production capacity is in Brazil (48 percent), followed by Mexico (29 percent), Argentina (10 percent), Colombia (8.0 percent) and Venezuela (5.0 percent).

The average annual consumption in Latin America and the Caribbean is about 40 kilos per inhabitant, and each year the region throws 3.7 million tons of plastic waste into rivers, lakes, seas and oceans, according to the United Nations Environment Program (UNEP).

Del Castillo, a senior lawyer at the Center for International Environmental Law (CIEL), warned that “if the trend is not reversed, by 2050 plastic production will reach 1.2 billion million tons annually. Paraphrasing (famed Colombian author of One Hundred Years of Solitude) Gabriel García Márquez, that is the size of our solitude.”

“That is why our main call is for an immediate moratorium on increased plastics production, followed by a phased out reduction in supply, and complemented by other crucial measures such as reuse and landfill systems,” del Castillo said from Geneva.

 

Volunteers from Peru’s Life Institute for Environmental Protection clean up plastic garbage washed up on the coast near Lima. In the waters surrounding cities, as well as in the oceans, discarded plastic waste that is not reused or recycled is added to other forms of pollution, severely affecting nature, including species and the landscape. CREDIT: IPMAV

 

Fearsome enemy

The plastic life chain is an enemy to health due to the release of more than 170 toxic substances in the production process of the raw material, in the refining and manufacture of its products, in consumption, and in the management and disposal of waste.

Once it reaches the environment, in the form of macro or microplastics, it accumulates in terrestrial and aquatic food chains, pollutes water and causes serious damage to human health, to animal species – such as aquatic species that die from consuming or being suffocated by these products – and to the landscape.

It also accounts for 12 percent of urban waste. UNEP estimates the social and economic costs of global plastic pollution to be between 300 billion dollars and 600 billion dollars per year.

It also affects the climate: the world’s 20 largest producers of virgin polymers employed in single-use plastics, led by the oil companies Exxon (USA) and Sinopec (China), generate 450 million tons a year of planet-warming greenhouse gases, almost as much as the entire United Kingdom.

And prominent villains are single-use plastics, such as packaging, beverage bottles and cups and their lids, cigarette butts, supermarket bags, food wrappers, straws and stirrers. Of these, 139 million tons were manufactured in 2021 alone, according to an index produced by the Australian Minderoo Foundation.

After alarm bells went off at the United Nations, the Intergovernmental Negotiating Committee on plastic pollution, composed of 175 countries, was created. It held its first two meetings last year, in Montevideo and Paris, and will hold its third in November in Nairobi, in a process aimed at drafting a binding international treaty on plastic pollution.

As if the boom in the production, consumption and improper disposal of plastics were not enough, the Latin American region is also importing plastic waste from other latitudes.

Studies by GAIA and the Peruvian investigative journalism website Ojo Público reported that in the last decade (2012-2022) Mexico, Ecuador, Peru, Chile and Colombia received more than one million tons of plastic waste from different parts of the world.

Although it is claimed that plastic waste is sold to be recycled into raw material for lower quality products or textiles, this rarely happens and it ends up adding to the millions of tons that go into landfills every year.

“We cannot even deal with our own waste and yet we are importing plastic garbage from other countries, often with very little clarity and transparency, so there is no traceability of what is imported under the pretext of recycling,” Briz complained.

 

Single-use plastics, more than a third of global production and ubiquitous in everyday life, are seen as the main villains in the entire plastics business chain, and Latin American and Caribbean countries are moving towards banning them altogether or at least limiting production and use. CREDIT: Goula

 

Laws and regulations are on their way

On the other side of the coin, in 2016 Antigua and Barbuda became the first country in the region to ban single-use plastic bags, and it has gradually expanded the ban to include polystyrene food storage containers, as well as single-use plates, glasses, cutlery and cups.

Since then, 27 of the 33 countries of Latin America and the Caribbean have enacted national or local laws to reduce, ban or eliminate single-use articles and, in some cases, other plastic products.

“There is a wide range: countries that already have strong rules to regulate plastics, especially single-use plastics, and they are applied. Others have very good regulations but they are not enforced. In others there are no regulations, and there are countries where nothing is happening,” Briz said.

In Argentina a 2019 resolution by the Ministry of Environment and Sustainable Development covers the life cycle of plastic (production, use, waste and pollution reduction) and a 2020 law bans cosmetic and personal hygiene products containing plastic microbeads.

Belize, Chile, Colombia, most Mexican states and Panama have passed regulations to progressively ban or limit the consumption of single-use plastics, as have Brazilian cities such as Rio de Janeiro and São Paulo. But in some cases there are doubts as to whether these provisions are effectively enforced.

Brazil has had a National Plan to Combat Marine Litter since 2019, which, however, has not yet been implemented. Costa Rica also has a National Marine Litter Plan, which seeks to reduce waste with the support of the communities.

Ecuador is turning the Galapagos Islands into a plastic-free archipelago, and phased out plastic bags, straws, “to-go” containers and plastic bottles in 2018.

Fences, including those made from recovered plastic waste, are being installed in rivers in Guatemala, Honduras, Panama and the Dominican Republic to collect plastic waste and prevent it from being washed out to sea.

In Guatemala, Castillo noted, the municipality of San Pedro La Laguna, in the Lake Atitlán basin, was a pioneer, banning sales of straws and plastic bags in 2016, and the city government won lawsuits in court over the ordinance. The example is spreading throughout the country.

 

View of a petrochemical plant of the Brazilian giant Braskem. Environmentalists’ demands for a halt to the expansion of plastics production focus on states in Mexico and Brazil, which have the largest petrochemical facilities in the Latin American region. CREDIT: Braskem

 

From landfills to petrochemicals

Del Castillo, the Ecuadorian expert, said that “apart from initiatives of a voluntary nature, regional action plans, and the regulation of single-use plastic products, the ongoing negotiation of an international treaty promises to be the path that has been chosen to put an end to plastic pollution.”

The treaty should cover “all emissions and risks from plastics during production, use, waste management and leakage,” del Castillo said, but “we don’t have to wait for the treaty to act: States can already say ‘No to the expansion of virgin plastics production’.”

The MarViva Foundation, which fights marine pollution in Colombia, Costa Rica and Panama, argues that “the best way to manage single-use plastic waste is not to create it,” and advocates discouraging the production, use and consumption of these materials.

But in the face of such proposals, “one of the biggest obstacles has to do with the economic power of the petrochemical industry, which refuses to reduce production. In Latin America, the largest producers of plastics are the petrochemical companies of Mexico and Brazil,” said Briz, the Ecuadorian biologist.

“Plastic is a cheap product, since its environmental and social costs are not taken into account, and while the cost of production and distribution is low, the cost for the health of people and the environment is not,” said the activist.

In short, for activists, an approach based only on recycling and bans will be of limited scope until a moratorium is imposed on the expansion of plastics production, with a global market worth 600 billion dollars a year and which at the current rate could triple in the next two decades.

A radio presenter in Sudan has a baby by the road as she flees militias she says killed her other sons.

Rescuers will make sure no-one is left beneath the rubble, vows a top official in the city of Douala.

Opponents call it a "plot on democracy" and say the referendum result should be annulled.

Amanda Ilestedt's last-minute header gives Sweden a 2-1 win over South Africa at the Women's World Cup in Wellington.

The Tate showcases Africa's past, present and future through the lenses of artists from the continent.

Hinata Miyazawa scores twice to help Japan to a 5-0 win against Fifa Women's World Cup debutants Zambia in New Zealand.

Polyamory is on the rise in South Africa as people break with tradition, counsellors say.

Armed men attacked a team taking supplies to one of only two hospitals open in southern Khartoum.

As the Women's World Cup gets under way in Australia and New Zealand, history-making Rwandan referee Salima Mukansanga details how she made it to the top.

Five-time African Footballer of the Year Asisat Oshoala on embracing pressure and fame as Nigeria's star player.

Nigeria's Onome Ebi still loves her football as she embarks on a sixth appearance at the Women's World Cup.

Dr Abhijit Bhattacharya, MS, Central Hospital Kalla, Eastern Coalfields Ltd., assesses an x-ray of a TB patient. Credit: ILO

By Ed Holt
BRATISLAVA, Jul 21 2023 (IPS)

In a surprise move, pharma giant Johnson and Johnson (J&J) has agreed not to enforce some of its patents on a lifesaving TB drug, making generic versions available in many low- and middle-income countries (LMICs).

Although on the WHO’s list of essential medicines and a cornerstone of much TB treatment, bedaquiline had not been available in many countries in part because of its high cost.

A deal agreed between J&J and the Stop TB Partnership will allow the latter to procure and supply generic bedaquiline to 44 low- and middle-income countries through its Global Drug Facility (GDF). It is expected the price at which these countries will then be able to buy the drug under the deal will be significantly lower than currently, and some experts have suggested it may also reduce the price of the drug for those countries not covered in the deal.

But patient advocacy groups say that while it is good news that many countries will now get the drug more cheaply, there remain some serious problems with the new deal as countries with some of the highest TB burdens in the world
are excluded. They are also unhappy that it does not address the enforcement of secondary patents the company has on altered formulations of the drug, which are in place in scores of LMICs until 2027.

Critics have called on J&J to declare it will not enforce any secondary patents on bedaquiline in any country with a high burden of TB and withdraw and abandon all pending secondary patent applications for this lifesaving drug.

“We hope this deal will help drive down the price of this drug for all countries. But it doesn’t go far enough. What would have been best would have been for J&J to abandon and withdraw all the secondary patents it holds or has applied for everywhere,” Lindsay McKenna, TB Project Co-Director at the Treatment Action Group (TAG), told IPS.

Advocacy organisations have for years been pressing J&J to reduce the price of bedaquiline.

First approved in 2012, it was the first new TB drug in over 40 years and was hailed as revolutionary in the fight against drug-resistant TB, cutting out the need to use often very toxic, intravenously administered drugs. Its use in patient regimens also produced vastly improved treatment outcomes.

But its high cost – initially USD900 per course even in low-income countries – meant that it was available to relatively few people in many low- and middle-income countries, which have some of the highest TB burdens in the world.

Its price has now come down but remains too high in the eyes of many experts.

According to global health charity Medicins Sans Frontieres (MSF), J&J currently prices the drug at USD1.50/day for an adult treatment (USD272/six months). But with scale-up and unrestricted generic competition, it says the price of bedaquiline could get closer to USD0.50 per day.

This would make a huge difference to cash-strapped TB programmes in poorer countries.

“Any penny that can be saved [on bedaquiline] and which can be spent on something else related to TB, such as case identification, is of massive importance, especially in countries with high TB burdens,” Christophe Perrin, TB advocacy pharmacist at MSF, told IPS.

But even if the deal does bring the price down to that level, some of the countries which would benefit from purchasing the drug at a lower price will not be able to as they have been excluded from it.

Nine countries in the Eastern European and Central Asian region, which have some of the highest TB burdens in the world, are not covered by the deal because of an exclusive supply agreement J&J has with a Russian pharma firm.

“This deal is beneficial for those countries which can access it, but why are some countries excluded? Those that are excluded have some of the highest TB burdens in the world. It’s a real worry,” said Perrin.

The exclusion has infuriated senior health officials in some of the excluded countries. In a rare instance of its kind, the national tuberculosis (TB) programme (NTP) of Belarus sent an open letter to J&J demanding urgent action to improve equitable access to bedaquiline in Belarus, and all other countries with a high burden of TB.

“It is completely unfair that we will be excluded from this deal,” Dr Alena Skrahina, Deputy National TB Programme Manager, Belarus, told IPS.

Another high-burden country that will not be able to take advantage is South Africa. The country’s national procurement rules mean that it obtains bedaquiline directly from J&J.

Doctors and patient activists involved in the country’s fight against TB say South Africa’s inclusion in the deal would have been a huge boon to its efforts against the disease.

“Any money that can be saved could be used to expand diagnosis, public awareness, and use shorter TB treatment regimens, which is what we are looking to do here. Almost 95% of our patients are receiving bedaquiline, so a reduction in the price could have a massive effect. It would definitely benefit South Africa if it was included in this deal,” Dr Priashni Subrayen, TB technical director at the Johannesburg-based healthcare organisation Aurum Institute, told IPS.

Brenda Waning, head of the GDF, told IPS the deal was a good one for LMICs, but could also theoretically benefit countries not covered by it. It is widely expected that the competitive tenders in the deal will push the global price of the drug down as well.

“The deal is special in that usually when a company like J&J gives out licences it does so to a supplier, but this deal allows for multiple competitive buyers. We are expecting the price of bedaquiline to go down, although we won’t know by how much until the tenders happen. But a lower price is not the only benefit for countries. It will also mean more suppliers – the last thing you want to be doing is relying on a single supplier for a drug so there will be greater supply security – and whenever you have a price decrease, that frees up money which can be used for other things [to fight TB],” she said.

“We think the access price [for other countries] may come down through these tenders, so these countries could, theoretically, get it at a lower price than previously,” she added.

But even if that does happen, it will not be enough for critics who say J&J must abandon secondary patents it holds, or has applied for, in any country.

Unlike primary patents, which protect a completely new chemical entity, secondary patents cover modifications of, medical uses, and dose regimes of the new compound, among others. Critics argue they form part of a practice of “evergreening” which extends companies’ monopolies on existing products and, crucially, makes it difficult for generic manufacturers to enter the market with a generic drug after the original patent has expired

J&J has secondary patents for bedaquiline in 44 countries which are not due to expire until 2027, but under the new deal with StopTB, those countries will now be able to obtain a generic version of the drug.

But they remain in place in those states – “if J&J were to suddenly pull out of this deal, these countries would be back to square one,” noted Perrin – and the company continues to actively pursue their implementation elsewhere.

Phumeza Tisile, a South African TB survivor who lost her hearing because of side effects of treatment with older generation TB drugs, said J&J, and other pharma companies, should immediately withdraw secondary patents and commit to not applying for them anywhere in future.

“This provides affordable medicine to people who need the drug [and] helps people get generic versions of the relevant medicine at a very low cost,” she told IPS.

Pharmaceutical firms often argue that secondary patents are necessary to recoup the often very high costs associated with bringing a novel drug to the market and invest in the production of other new medicines.

J&J did not respond when contacted by IPS, but in a statement made as news of the deal broker last week, the company denied its patents had prevented people from accessing its drug and that the most significant barrier to treatment access for patients was the millions of undiagnosed TB cases every year.

Tisile, who works for advocacy group TB Proof, dismissed such claims, saying secondary patents may be denying people the drugs which they need to stop them dying.

“It’s greed,” she said. “Pharma companies make medicines to help people, but it never made sense to me that they make this medication so out of reach to people who actually need the medication the most, for them, it’s only profits. “This then can be very dangerous to millions of people who need the medication to survive. In this case, it should be patients before profits,” she said.

Others pointed out that the development of many new drugs is often funded by taxpayers – one study found that public investment into bedaquiline’s development was as much as five times that of J&J.

“It’s not a good faith argument to say that secondary patents are needed for a company to benefit from its investment in a drug. You could flip that round and say that the public needs to benefit from the investment they made into a drug,” said McKenna.

IPS UN Bureau Report

 

Follow @IPSNewsUNBureau
!function(d,s,id){var js,fjs=d.getElementsByTagName(s)[0],p=/^http:/.test(d.location)?'http':'https';if(!d.getElementById(id)){js=d.createElement(s);js.id=id;js.src=p+'://platform.twitter.com/widgets.js';fjs.parentNode.insertBefore(js,fjs);}}(document, 'script', 'twitter-wjs');   Related Articles

• Marginalising Key Populations Impacting Efforts to End HIV/AIDS Epidemic
• Ukraine: Environmental Crisis Compounds Humanitarian Disaster Following Dam Destruction
• Tuberculosis Risk Factors Exacerbated by Climate Change